Alternatives to Ella Therapeutics

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.

Global biopharmaceutical company focused on oncology and neuroscience treatments.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Develops and commercializes a novel cancer treatment technology called Alpha DaRT.

AI-driven digital twin of embryo development for cell-based therapies.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Biotechnology company developing novel therapies for multiple myeloma.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

AI-powered insights platform for life sciences and biotech workflows.

Compressing biology to develop the next generation of therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Develops autologous engineered tissue from omentum biopsies for medical conditions.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

AI-powered spatial biology platform for precision medicine and drug development.

Bio-pharmaceutical company developing novel, biologically sourced therapies for animal and human health.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.

AI-powered platform for designing novel molecular structures for new medicines.